In addition, similar to our discussion in the FY 2021 IPPS/LTCH PPS final rule (85 FR 58886 through 58887), in the CY 2026 OPPS/ASC proposed rule we stated that, if the proposed policy were finalized, we would intend to provide additional opportunity for the public to review the MAO median payer-specific negotiated charge data received prior to the utilization of this data in the market-based MS-DRG relative weight methodology beginning in FY 2029
Pain & Inflammation Relief: Certain IV formulations can provide targeted relief for pain and inflammation associated with conditions like migraines, allergies, and chronic injuries
Some of these medications use different active ingredients, ways of taking the drug, and dosing schedules
Segmental: This kind only impacts a single part of your body, such as your face or hands
The peptide belongs to a class of compounds known as growth hormone fragments or lipolytic peptides
Low-molecular-weight heparins (LMWH) enoxaparin (Lovenox, J1650), dalteparin (Fragmin, J1645), fondaparinux (Arixtra, J1652) Oral anticoagulation (DOACs Direct Oral Anticoagulants): Rivaroxaban (Xarelto), apixaban (Eliquis), dabigatran (Pradaxa), edoxaban (Savaysa) reported via NDC on Medicare Part D claims Vitamin K antagonist: Warfarin (Coumadin) oral, Part D NDC
